申请人:Tularik, Inc.
公开号:US20010018430A1
公开(公告)日:2001-08-30
The invention provides compounds, compositions and methods relating to novel arylsulfonanilide derivatives and their use as pharmacologically active agents. The compositions find particular use as pharmacological agents in the treatment of disease states, particularly cancer, psoriasis, vascular restenosis, infections, atherosclerosis and hypercholesterolemia, or as lead compounds for the development of such agents.
该发明提供了与新型芳基磺酰苯胺衍生物相关的化合物、组合物和方法,以及它们作为药理活性剂的用途。这些组合物在治疗疾病状态中特别用作药理剂,尤其是癌症、银屑病、血管再狭窄、感染、动脉粥样硬化和高胆固醇血症,或作为开发这些药理剂的引领化合物。